コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 insulin resistance, multiple sclerosis, and idiopathic thrombocytopenic purpura.
2 a panel to develop a practice guideline for idiopathic thrombocytopenic purpura.
3 ctiveness of any treatment for patients with idiopathic thrombocytopenic purpura and persistent sever
4 telet production (Essential Thrombocythemia, Idiopathic Thrombocytopenic Purpura) and decreased upon
5 ause there are no specific tests that define idiopathic thrombocytopenic purpura, and management deci
6 on in various platelet disorders, especially idiopathic thrombocytopenic purpura, before consideratio
7 that the patient suffers from a rare form of idiopathic thrombocytopenic purpura caused by a GPVI-spe
8 if they were more than 16 years of age, had idiopathic thrombocytopenic purpura for more than 3 mont
9 aemorrhagic (IRR 1.47, 95%CI: 1.04-2.08) and idiopathic thrombocytopenic purpura (IRR 2.80, 95%CI: 1.
13 on was found between ChAdOx1 vaccination and idiopathic thrombocytopenic purpura (ITP) (0-27 d after
15 a standard treatment for adult patients with idiopathic thrombocytopenic purpura (ITP) for more than
16 astic bone marrow patient and a patient with Idiopathic Thrombocytopenic Purpura (ITP) for the same p
22 s from 63 sites in 23 countries with chronic idiopathic thrombocytopenic purpura (ITP), platelet coun
23 th platelet destructive disorders, including idiopathic thrombocytopenic purpura (ITP), posttransfusi
24 ic disorders, the authors concluded that, in idiopathic thrombocytopenic purpura (ITP), production of
25 a associated with myelodysplastic syndromes, idiopathic thrombocytopenic purpura, thrombocytopenia du